
The Public Health Ministry plans to treat Covid-19 patients at risk of complications with long-acting antibodies (LAAB), according to the Department of Disease Control.
LAAB are now administered as pre-infection protection.

The Public Health Ministry plans to treat Covid-19 patients at risk of complications with long-acting antibodies (LAAB), according to the Department of Disease Control.
LAAB are now administered as pre-infection protection.